title: Molecular epidemiology of factor IX germline mutations in Mexican Hispanics: pattern of mutation and potential founder effects.
abstract: Germline mutations in patients with hemophilia B generally have arisen within the past 150 years. Evidence suggests that these germline mutations generally result from endogenous processes. However, a unique pattern would be expected if a population were exposed to a physiologically important germline mutagen since mutagens generally produce characteristic patterns, or "fingerprints", of mutation. To determine the pattern of mutation in Mexican Hispanics, the regions of likely functional significance in the factor IX gene were screened by dideoxy fingerprinting (ddF) in 31 families with hemophilia B. Mutations were found in 30 of these families. Haplotype analysis was performed on individuals with identical mutations to help distinguish independent, recurrent mutations from founder effects. Analysis of these 30 mutations, along with 7 mutations reported previously in Mexican Hispanic families, reveals a pattern of independent mutation that is similar to the pattern of mutation observed in 127 U.S. Caucasian families (p = 0.89). These results may reflect either an underlying pattern of germline mutation due to endogenous processes or the presence of an ubiquitous mutagen. Further analyses of the recurrent mutations revealed that two mutations, T296M and R248Q, accounted for 19% of the mutations found in the Mexicans. Haplotype data suggest that the multiple occurrences of T296M and R248Q are associated with founder effects and that screening for these mutations may allow rapid mutation detection and carrier diagnosis in a significant minority of Mexican families with hemophilia B, These two mutations also are associated with founder effects in the U.S, Caucasian population. However, the haplotypes are different in these two populations, indicating independent origins. The occurrence of identical founder mutations in distinct populations provides evidence for the previous hypothesis that the number of different mutations giving rise to mild or borderline mild/moderate hemophilia B is small compared to deleterious mutations causing more severe disease.
authors.affiliation: Department of Biochemistry and Molecular Biology, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA.
authors.forename: E C
authors.initials: EC
authors.lastname: Thorland
authors.forename: B G
authors.initials: BG
authors.lastname: Weinshenker
authors.forename: J Z
authors.initials: JZ
authors.lastname: Liu
authors.forename: R P
authors.initials: RP
authors.lastname: Ketterling
authors.forename: E L
authors.initials: EL
authors.lastname: Vielhaber
authors.forename: C K
authors.initials: CK
authors.lastname: Kasper
authors.forename: R
authors.initials: R
authors.lastname: Ambriz
authors.forename: R
authors.initials: R
authors.lastname: Paredes
authors.forename: S S
authors.initials: SS
authors.lastname: Sommer
mesh_terms: D005164:Factor IX / Q000235:genetics*; D005260:Female; D018703:Founder Effect; D018095:Germ-Line Mutation; D006239:Haplotypes; D002836:Hemophilia B / Q000453:epidemiology / Q000235:genetics*; D006801:Humans; D008297:Male; D008800:Mexico / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D044465:White People / Q000235:genetics
chemical_list: D005164:Factor IX